adamantane has been researched along with Chronic Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Boulton, DW; Butrovich, MA; Nolin, TD; Sharma, P; Tang, W | 1 |
| Chen, Z; Dong, W; Fu, R; Li, K; Li, X; Li, Y; Ma, X; Tian, X; Wang, J; Wang, L; Yao, T; Zhang, Y; Zhao, W | 1 |
| Bhatt, DL; Braunwald, E; Im, K; Kanevsky, E; McGuire, DK; Mosenzon, O; Raz, I; Scirica, BM; Sjöstrand, M; Stahre, C; Steg, PG; Udell, JA | 1 |
| Bauer, E; Huang, H; Lang, K; Shetty, S | 1 |
| Tuttle, KR | 1 |
| Charbonnel, B; Dejager, S; Schweizer, A | 1 |
| Bakris, GL; Flynn, C | 1 |
2 review(s) available for adamantane and Chronic Kidney Diseases
| Article | Year |
|---|---|
Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?
Topics: Adamantane; Body Weight; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Drug Therapy, Combination; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Linagliptin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Triazoles; Uracil; Vildagliptin | 2013 |
Noninsulin glucose-lowering agents for the treatment of patients on dialysis.
Topics: Adamantane; Biguanides; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Disease Progression; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Linagliptin; Meglumine; Metformin; Nitriles; Piperidines; Purines; Pyrazines; Pyrrolidines; Quinazolines; Renal Dialysis; Renal Insufficiency, Chronic; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Triazoles; Uracil; Vildagliptin | 2013 |
1 trial(s) available for adamantane and Chronic Kidney Diseases
| Article | Year |
|---|---|
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.
Topics: Adamantane; Albuminuria; Biomarkers; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diabetic Nephropathies; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hospitalization; Humans; Incretins; Male; Renal Insufficiency, Chronic | 2018 |
4 other study(ies) available for adamantane and Chronic Kidney Diseases
| Article | Year |
|---|---|
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4-Mediated Metabolism of Saxagliptin.
Topics: Adamantane; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dipeptides; Drug Interactions; Humans; Models, Biological; Renal Insufficiency, Chronic | 2022 |
Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells.
Topics: Adamantane; Animals; Blotting, Western; Case-Control Studies; Cell Line; Dipeptidases; Dipeptides; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Epithelial-Mesenchymal Transition; Fibrosis; Fluorescent Antibody Technique; Humans; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic | 2021 |
Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease.
Topics: Adamantane; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Humans; Hypoglycemic Agents; Linagliptin; Male; Middle Aged; Renal Insufficiency, Chronic; Retrospective Studies; Sitagliptin Phosphate | 2018 |
SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease.
Topics: Adamantane; Albuminuria; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Glucosides; Humans; Incretins; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 | 2019 |